Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. - Wikidata - awgldk - TriplyDB

Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality.

Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality.

http://www.wikidata.org/entity/Q41723281

about

Sarcopenia and Physical Inactivity in Patients With Chronic Kidney Disease Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors.The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach.Factors associating with oxygenation of lower-limb muscle tissue in hemodialysis patients.Sarcopenia in cases of chronic and acute illness. A mini-review.Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease.Clinical relevance of sarcopenia in chronic kidney disease.Muscle wasting in chronic kidney disease.As we grow old: nutritional considerations for older patients on dialysis.Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5.Low Lean Mass With and Without Obesity, and Mortality: Results From the 1999-2004 National Health and Nutrition Examination Survey.Nutritional assessment of elderly patients on dialysis: pitfalls and potentials for practice.Physical function was related to mortality in patients with chronic kidney disease and dialysis.The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney Disease.Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.Low-protein diets for chronic kidney disease patients: the Italian experience.Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease.Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.Morphometric age and survival following kidney transplantation.Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease.Factors Associated with the Serum Myostatin Level in Patients Undergoing Peritoneal Dialysis: Potential Effects of Skeletal Muscle Mass and Vitamin D Receptor Activator Use.Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease.Poor Physical Function as a Marker of Sarcopenic Obesity in Adults with Class II/III Obesity Rectus femoris muscle mass evaluation by ultrasound: facilitating sarcopenia diagnosis in pre-dialysis chronic kidney disease stages The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review Nutrition Trends in Kidney Transplant Recipients: the Importance of Dietary Monitoring and Need for Evidence-Based Recommendations

P2860

Q26738457-2193479E-3769-4700-8856-33C4C85D6833 Q33610729-F7E2A810-A02F-40EB-9AF8-C768D0ACA8CE Q33616803-C10EDDDD-360C-4F43-93CD-294B8BD95A4D Q37399690-1C6D5C28-CC19-4B1F-AF91-5AC97E46AA9E Q38648849-FD5910A5-7A83-420E-805B-A242B489217C Q38691312-04501083-3021-4E5A-AB9D-9FF8AB696197 Q38757331-7196D329-BAA0-470F-9E76-91FEF3E47F9C Q38784295-FCBB4AF9-A28C-49C9-8D8A-18049726A652 Q38840709-55F59D79-766D-4820-9DB7-686224E9F1D3 Q38878535-80B17147-9212-4E76-8230-DA3BCF5AF865 Q38957850-7EC01765-86E6-4300-B01C-FAEEE38724C7 Q39216984-5F3A9802-2D7B-4CD7-97D5-7249CDDA519E Q39248170-06571379-066C-45A1-AB15-DC732685564A Q40095248-7B6376C1-E0BA-4020-89BA-76617A7C4973 Q40365771-98F84087-2721-47F8-A43B-0235F39D269D Q42426578-4331BE7C-7CD5-42A6-BCDB-BD6B28A7B705 Q42784003-E377B60D-4879-4A7C-9891-998419D9706D Q47648052-13BDD9EB-3D54-4896-9148-6DF4A6340340 Q48323249-B2352307-83C1-4BE6-B1B9-EBCB1027CB36 Q49979500-ED953BA5-DD17-4060-9402-5D6162C33B27 Q53170546-E0DE1C26-CF0B-4119-BB03-ADD11DBC2FA2 Q53685290-B7DE26A0-9AA7-4350-A9E5-7B08E2AAFEF1 Q57314867-0F5E6629-0C39-453E-BF27-7894D366BF3C Q58102088-587D2FDD-D357-4077-9253-F0CC4C9579B2 Q58568715-11E6525C-6B5B-4672-89A2-78E3B80D62BA Q59138050-A51AE640-03C5-4313-955C-E01DCB339DA2

P2860

Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality.

http://www.wikidata.org/entity/Q41723281

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Sarcopenia in chronic kidney d ...... nd association with mortality.

@en

type

label

Sarcopenia in chronic kidney d ...... nd association with mortality.

@en

prefLabel

Sarcopenia in chronic kidney d ...... nd association with mortality.

@en

P1433

Q41723281-0CAD1CD8-5483-44F3-B412-9523D8F623ED

P1476

Q41723281-71A47E65-8797-4762-B3F9-68A797B27CB1

P2093

Q41723281-0761C197-DD87-47AD-A276-CFD071DBFC93

Q41723281-10E168A7-1672-4B6B-BEAB-743F986BDB02

Q41723281-16722FEE-DAB5-4796-828E-CD6B61876A16

Q41723281-3FA45227-097D-4C7C-8C94-2D90CFA2C125

Q41723281-54058567-7500-4DEC-90DD-F63A7958054A

Q41723281-9675A997-0378-4255-A8B3-7E5F466730D1

Q41723281-9EEEC50A-AFFA-4E2A-B403-415AC5A3000D

Q41723281-AEBDFF56-2BE2-4BBF-8799-CB162FE29A8B

P2860

Q41723281-01A75D96-4C3F-47DC-B066-B8A66D73A871

Q41723281-048DB611-88A4-434B-9B08-B429DC3E78B8

Q41723281-0AECBA56-EBBF-470E-962E-39105BD57BCA

Q41723281-0D1DEF26-6045-49CC-AFA0-A337169B0F01

Q41723281-0EA77DBC-2FAC-464C-859B-5F14E4639BDF

Q41723281-12AC1BF3-F4DA-4C6D-B2F3-9E5BE13BAB1B

Q41723281-22E532B8-85CF-4F78-AD53-3F35DFACFEC0

Q41723281-3385E26C-E40B-4FF6-AA40-ABFC4BDE8C1C

Q41723281-34CF4078-A6AA-4A9F-AE6A-250B522B5B64

Q41723281-3C6D407F-EE8C-4EB8-8A19-4F7D4D9E05EC

P304

Q41723281-B4FDB5F3-D9C3-4061-A3A1-498A86914516

P31

Q41723281-7278D050-ECE6-4279-864B-4A0740E39A18

P356

Q41723281-75F5B3AF-A23A-4070-A652-A84335AB0BB7

P407

Q41723281-020D2424-C53A-4E37-94DC-5DD28B2E8FDF

P433

Q41723281-8836D952-430C-4623-9EFB-8D241C92E553

P478

Q41723281-002DA156-08DE-481D-B4D5-B78CDAF5DD9E

P50

Q41723281-A0AA70A9-ED11-4250-923F-677B90322E00

P577

Q41723281-55CE2ACF-47F1-4BCB-82A3-92B0C61557A4

P5875

Q41723281-2B0D126C-9A0E-42C2-8B6F-633FB928D871

P698

Q41723281-739D1431-FFB6-4B79-BB94-171BA11CD0E1

P356

P1433

Nephrology Dialysis Transplantation

P1476

Sarcopenia in chronic kidney d ...... nd association with mortality.

@en

P2093

Antonio C Cordeiro

http://www.w3.org/2001/XMLSchema#string

Carla M Avesani

http://www.w3.org/2001/XMLSchema#string

Celso Amodeo

http://www.w3.org/2001/XMLSchema#string

Fernanda C Amparo

http://www.w3.org/2001/XMLSchema#string

Juan J Carrero

http://www.w3.org/2001/XMLSchema#string

Lilian Cuppari

http://www.w3.org/2001/XMLSchema#string

Maria A Kamimura

http://www.w3.org/2001/XMLSchema#string

Raíssa A Pereira

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

Epidemiology of sarcopenia among the elderly in New Mexico

Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"

Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS)

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Sarcopenia with limited mobility: an international consensus.

Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients

Review of muscle wasting associated with chronic kidney disease.

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia

Mortality as an adverse outcome of sarcopenia.

P304

1718-1725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFV133

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277080592

http://www.w3.org/2001/XMLSchema#string

P698

25999376

http://www.w3.org/2001/XMLSchema#string